Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Time trends and local variation in primary treatment of localized prostate cancer.

Cooperberg MR, Broering JM, Carroll PR.

J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.

PMID:
20124165
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

Cancer. 2006 Apr 15;106(8):1708-14.

PMID:
16544313
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.

Cooperberg MR, Vickers AJ, Broering JM, Carroll PR.

Cancer. 2010 Nov 15;116(22):5226-34. doi: 10.1002/cncr.25456. Erratum in: Cancer. 2011 Jun 15;117(12):2825.

PMID:
20690197
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).

Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR.

J Urol. 2005 May;173(5):1557-61.

PMID:
15821485
[PubMed - indexed for MEDLINE]
5.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
[PubMed - indexed for MEDLINE]
6.

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA.

J Clin Oncol. 2010 Feb 20;28(6):1069-74. doi: 10.1200/JCO.2009.26.2469. Epub 2010 Jan 25.

PMID:
20100957
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.

Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR.

J Urol. 2002 Aug;168(2):530-5.

PMID:
12131303
[PubMed - indexed for MEDLINE]
8.

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.

Cooperberg MR, Broering JM, Carroll PR.

J Natl Cancer Inst. 2009 Jun 16;101(12):878-87. doi: 10.1093/jnci/djp122. Epub 2009 Jun 9.

PMID:
19509351
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE.

Park S, Meng MV, Elkin EP, Speight JL, DuChane J, Carroll PR.

J Urol. 2005 Nov;174(5):1802-7.

PMID:
16217291
[PubMed - indexed for MEDLINE]
10.

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR.

J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24. Epub 2007 Oct 9.

PMID:
17925537
[PubMed - indexed for MEDLINE]
Free Article
11.

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.

Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR.

J Clin Oncol. 2004 Jun 1;22(11):2141-9.

PMID:
15169800
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.

Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR; CaPSURE Investigators.

J Urol. 2007 Aug;178(2):529-34; discussion 534. Epub 2007 Jun 13.

PMID:
17570425
[PubMed - indexed for MEDLINE]
13.

Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.

J Urol. 2005 Apr;173(4):1126-31.

PMID:
15758720
[PubMed - indexed for MEDLINE]
14.

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP.

Cancer. 2005 Feb 1;103(3):538-45.

PMID:
15612083
[PubMed - indexed for MEDLINE]
Free Article
15.

Impact of national guidelines on brachytherapy monotherapy practice patterns for prostate cancer.

Tseng YD, Paciorek AT, Martin NE, D'Amico AV, Cooperberg MR, Nguyen PL.

Cancer. 2014 Mar 15;120(6):824-32. doi: 10.1002/cncr.28492. Epub 2013 Dec 2.

PMID:
24301555
[PubMed - indexed for MEDLINE]
16.

Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.

Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H.

J Clin Oncol. 2009 Sep 10;27(26):4306-13. doi: 10.1200/JCO.2008.21.5228. Epub 2009 Aug 10.

PMID:
19667269
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.

Chen RC, Sadetsky N, Chen MH, Carroll PR, D'Amico AV.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):36-9. doi: 10.1016/j.ijrobp.2008.10.059. Epub 2009 Feb 23.

PMID:
19233568
[PubMed - indexed for MEDLINE]
18.

Trends of the primary therapy for patients with prostate cancer in Nara uro-oncological research group (NUORG): a comparison between the CaPSURE data and the NUORG data.

Tanaka N, Fujimoto K, Hirayama A, Yoneda T, Yoshida K, Hirao Y.

Jpn J Clin Oncol. 2010 Jun;40(6):588-92. doi: 10.1093/jjco/hyq008. Epub 2010 Mar 18.

PMID:
20299498
[PubMed - indexed for MEDLINE]
Free Article
19.

Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.

Kollmeier MA, Stock RG, Stone N.

Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):645-53.

PMID:
14529768
[PubMed - indexed for MEDLINE]
20.

Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in community practice.

Hattangadi JA, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV.

Brachytherapy. 2011 Sep-Oct;10(5):369-75. doi: 10.1016/j.brachy.2011.01.004. Epub 2011 Feb 24.

PMID:
21349778
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk